Marijuana-based drug reduces back pain in large study
New study shows marijuana-based drug reduces back pain significantly compared to placebo.
Why it matters
- Offers an alternative to opioids for chronic pain management.
- Supports the therapeutic potential of cannabis.
By the numbers
- 800 patients participated.
- Nearly 2-point reduction in pain on an 11-point scale.
- 17% dropout rate due to side effects.
The big picture
- Chronic back pain affects millions and has few proven treatments.
- This drug provides a new option without the risks of opioids.
What they're saying
- Some commenters are skeptical about the clinical relevance of the pain reduction.
- Concerns about pharma sponsorship and the need for rigorous research.
Caveats
- Study was sponsored by the drugmaker.
- Pain reduction might not be clinically significant for some.
What’s next
- Vertanical is seeking approval in Europe and working with U.S. regulators.